Medline Stock Now Available to Trade

Medline (MDLN.O) has made a powerful entrance into public markets, surging 41% on its Nasdaq debut following the largest IPO of 2025 so far. The strong first-day performance highlights renewed investor appetite for high-quality healthcare and industrial names, even amid broader market uncertainty.

A Landmark IPO

Medline officially began trading on Nasdaq after raising billions in a blockbuster listing that quickly became the standout IPO of the year. Demand was strong from both institutional and retail investors, driving shares sharply higher in early trading.

Why Medline Is a Stock to Watch

Founded more than 50 years ago, Medline is one of the world’s largest suppliers of medical and surgical products, serving hospitals, clinics, and healthcare providers across the globe. Its catalogue includes hundreds of thousands of medical supplies, ranging from basic consumables to advanced healthcare equipment.
In a market often dominated by technology IPOs, Medline’s debut stands out as a reminder that fundamentals still matter.

Trade Medline with FxPro

You can now trade Medline shares with FxPro and take advantage of post IPO volatility as the stock finds its footing in public markets.

With FxPro, you can:

• Trade Medline from 0.01 shares
  
• Go long or short depending on market direction
  
• Trade via MT5 or the FxPro App
  
• Benefit from fast execution and tight spreads
  
• Access new stocks, including major IPOs, as they become available

Medline’s strong debut makes it a stock worth watching as 2025’s IPO calendar gathers momentum.

Trade responsibly.
CFDs and Spread Betting are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs and Spread Betting with this provider. You should consider whether you understand how these products work and whether you can afford to take the high risk of losing your money.